首页> 外国专利> NOVEL METALLO-BETA-LACTAMASE INHIBITOR CREATED IN MULTI-DRUG RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR

NOVEL METALLO-BETA-LACTAMASE INHIBITOR CREATED IN MULTI-DRUG RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR

机译:在多毒性细菌中产生的新型金属β-内酰胺酶抑制剂,制备方法

摘要

The present invention relates to a novel metallo-beta-lactamase (MBL) inhibitor and an antibacterial composition to be used against multi-drug resistant bacteria, containing same, and is a compound of chemical formula 1 or a derivative thereof, and, more specifically, is 3,5-dichlorophenylboronic acid, (4-(4-amino-3- chlorophenoxy)-3,5-dichlorophenyl) boronic acid and (3,5-dichloro-4-(2-hydroxyethoxy)phenyl)boronic acid. An MBL inhibitor of chemical formula 1, according to the present invention, has an inhibitory activity against a broad spectrum of MBLs. Therefore, when an MBL according to the present invention and an antibiotic having a β-lactam structure are used together in treatment, degradation of the antibiotic due to MBL produced by microorganisms is prevented so that the duration of action and range of the antibiotic can be extended, and bacteria that can acquire resistance to an antibiotic due to the presence of MBL can be killed, and thus infection by multi-drug resistant bacteria is effectively prevented and treated.
机译:本发明涉及一种新的金属β-内酰胺酶(MBL)抑制剂和抗菌组合物,其含有相同的多药物耐药细菌,并且是化学式1或其衍生物的化合物,更具体地,是3,5-二氯苯基硼酸,(4-(4-氨基-3-氯苯氧基)-3,5-二氯苯基)硼酸和(3,5-二氯-4-(2-羟基乙氧基)苯基)硼酸。根据本发明的化学式1的MBL抑制剂具有针对广谱的抑制活性抵抗广谱的MBL。因此,当根据本发明的MBL和具有β-内酰胺结构的抗生素一起使用时,防止由于微生物产生的MBL引起的抗生素的降解,因此可以是抗生素的作用持续时间和抗生素的范围可以杀死延长,并且可以杀死由于存在MBL的存在而获得抗生素的抗性的细菌,因此有效地防治了多毒性细菌的感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号